help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on January 11, 2007, doi:10.1165/rcmb.2006-0385OC

Am. J. Respir. Cell Mol. Biol., Volume 36, Number 5, May 2007, 573-584

A more recent version of this article appeared on May 1, 2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2006-0385OCv1
36/5/573    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Van Hove, C. L
Right arrow Articles by Tournoy, K. G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van Hove, C. L
Right arrow Articles by Tournoy, K. G

Submitted on October 13, 2006
Revised on January 10, 2007

Prolonged Inhaled Allergen Exposure Can Induce Persistent Tolerance

Chris L Van Hove1, Tania Maes1, Guy F Joos1, and Kurt G Tournoy1*

1 Faculty of Medicine and Ghent University Hospital, Department of Respiratory Diseases, Ghent University, Ghent, Belgium

* To whom correspondence should be addressed. E-mail: kurt.tournoy{at}UGent.be.

ABSTRACT Murine asthma models suggest that failure of immune tolerance rather than a defective Th-1 immunity underlies the immune-biology of Th-2 driven allergen induced airway disease. Intriguingly, prolonged exposures result in a full waning of inflammation. The mechanisms underlying this observation are not understood. We hypothesized that the fading of inflammation is the result of regulatory processes, characterized by altered dendritic cell (DC) -T cell interactions. First, we implemented a model in which mice developed Th-2 driven airway disease. When we subjected these mice to prolonged antigen ovalbumin (OVA) exposures (8 weeks), all inflammation disappeared. Re-immunization and re-challenge showed an inability to mount Th-2 skewed immune responses, with absence of airway eosinophils, IgE and Th-2 cytokines. Besides specific immune tolerance, bystander protection was observed. A decrease in CD4+CD25+Foxp3+ T-regulatory cells, PD-1 and IL-10 expression was discerned as compared to acute inflammation. In addition, suppression of ICOS and CD28 was found, along with inhibited DC maturation. This process of disease inhibition surprisingly had a long lasting memory and was not caused by endotoxin signalling through TLR-4. In summary, our results indicate that the disappearance of Th-2 driven airway disease upon persistent antigen exposure is associated with the induction of immune tolerance. The tolerant state is antigen dependent, and extends to bystander antigens. Moreover, this tolerance is characterized by an altered DC-T-cell communication and is long lasting. Our data further suggest that the mechanism of the disease inhibition following allergic airway inflammation differs from the anti-inflammatory mechanisms observed during acute eosinophilic airway inflammation.




This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
M. Hewitt, A. Creel, K. Estell, I. C. Davis, and L. M. Schwiebert
Acute Exercise Decreases Airway Inflammation, but Not Responsiveness, in an Allergic Asthma Model
Am. J. Respir. Cell Mol. Biol., January 1, 2009; 40(1): 83 - 89.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. Bogaert, K. G. Tournoy, T. Naessens, and J. Grooten
Where Asthma and Hypersensitivity Pneumonitis Meet and Differ: Noneosinophilic Severe Asthma
Am. J. Pathol., January 1, 2009; 174(1): 3 - 13.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Singh, W. F. Carson IV, E. R. Secor Jr, L. A. Guernsey, R. A. Flavell, R. B. Clark, R. S. Thrall, and C. M. Schramm
Regulatory Role of B Cells in a Murine Model of Allergic Airway Disease
J. Immunol., June 1, 2008; 180(11): 7318 - 7326.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. L. Van Hove, T. Maes, G. F. Joos, and K. G. Tournoy
Comment on "A Novel Pathway that Regulates Inflammatory Disease in the Respiratory Tract"
J. Immunol., June 15, 2007; 178(12): 7501 - 7501.
[Full Text] [PDF]


Home page
J. Immunol.Home page
N. Niu and L. Cohn
Response to Comment on "A Novel Pathway That Regulates Inflammatory Disease in the Respiratory Tract"
J. Immunol., June 15, 2007; 178(12): 7501 - 7502.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2007 American Thoracic Society.
  ATS Best of the Web